Top Markets
Coin of the day
LifeMD, Inc. LifeMD, Inc.

LifeMD, Inc.

LFMDP
Classement en actions #6273
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects... LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
Prix de l'action
$23.31
Capitalisation boursière
$1.05B
Changement (1 jour)
-0.81%
Changement (1 an)
-6.37%
Pays
US
Échange LifeMD, Inc. (LFMDP)

Catégorie

Ratio P/E pour LifeMD, Inc. (LFMDP)
Ratio P/E au March 2026 TTM : 12.04
Selon les derniers rapports financiers et le cours de l'action de LifeMD, Inc., le ratio P/E actuel (TTM) est de 12.04. À la fin de l’année 2023, le P/E de l’entreprise était de -13.65.
Historique du ratio P/E pour LifeMD, Inc. de 2011 à 2026
Ratio P/E à la fin de chaque année
Année Ratio P/E Changez
2026 (TTM) 12.04 -211.44%
2024 -10.80 -20.86%
2023 -13.65 922.40%
2022 -1.33 -21.69%
2021 -1.70 10.66%
2020 -1.54 -8.50%
2019 -1.68 -66.24%
2018 -4.99 -59.79%
2017 -12.40 49.85%
2016 -8.27 -86.13%
2015 -59.64 804.23%
2014 -6.60 -76.83%
2013 -28.47 188.12%
2012 -9.88 -33.88%
2011 -14.95 0.00%
Ratio P/E pour des entreprises similaires ou concurrentes
Entreprise P/E Ratio Différence du P/E Ratio Pays
30.93 156.99%
HK
31.77 163.96%
BR
17.49 45.30%
JP
18.15 50.80%
CN
14.54 20.82%
JP
Comment lire un P/E ratio ?

Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.

Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.

Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.